Tap to enable a layout that focuses on the article.
Advertisement
Science & Medicine

For the record - July 13, 2009

L.A. Times Archives

Cancer vaccines: An article in the July 6 Health section about vaccines used to fight cancer stated that the vaccine BiovaxID delayed remission of lymphoma patients after chemotherapy by more than one year, on average. BiovaxID prolonged -- not delayed -- remission by more than one year.

Science & MedicineWorld & Nation

Sign up for Climate | Health | Science

A weekly round-up of the latest in science, health and the environment.

By continuing, you agree to our Terms of Service, which include arbitration and a class action waiver. You agree that we and our third-party vendors may collect and use your information, including through cookies, pixels and similar technologies, for the purposes set forth in our Privacy Policy such as personalizing your experience and ads.

More From the Los Angeles Times

Advertisement
Advertisement